Raluca Ana Maghinici

Ms. Raluca Ana Maghinici

Chemistry, Dunarea de Jos University of Galati, Galaţi, Romania
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2025 in Chemosensors
Verified
Journal Article
Open access
PDF file
Raluca Ana MaghiniciRaluca Ana Maghinici
Raluca Ana Maghinici
Alexandra Virginia BounegruAlexandra Virginia Bounegru
Alexandra Virginia Bounegru
Constantin ApetreiConstantin Apetrei
Constantin Apetrei
In recent years, interest in screen-printed electrodes (SPEs) has grown due to their wide range of applications. Diclofenac (DCF), a widely used non-steroidal anti-inflammatory drug, is a subject of interest in pharmaceutical research as well as environmental research, primarily due to its environmental contamination and therapeutic applications. This study describes the development and characterization of an innovative screen-printed sensor based on graphene oxide (GO) and phenanthroline (PHEN) for the rapid and highly sensitive determination of diclofenac. The modified sensor was characterized by Fourier Transform Infrared (FT-IR) spectroscopy and scanning electron microscopy (SEM). The electrochemical behavior of the screen-printed electrodes was assessed through cyclic voltammetry (CV) in phosphate buffer solution (PBS) and potassium ferrocyanide/potassium ferricyanide solution. The cyclic voltammograms of the electrodes modified with GO and PHEN revealed peaks in PBS related to redox processes of PHEN immobilized in the carbonaceous matrix. Additionally, the active surface area of the electrodes was found to be larger for the modified carbon screen-printed electrode with GO and PHEN, which also showed improved sensitivity to the detection of DCF. The limit of detection (1.53 nM) and the sensitivity of the novel sensor were promising, and these performance characteristics enabled the sensitive detection of DCF in different pharmaceutical products. The selectivity was confirmed to be appropriate based on recovery studies conducted with the pharmaceutical products, which produced values close to 100%.

3 April 2026 in Chemosensors
Verified
Journal Article
Open access
PDF file
Raluca Ana MaghiniciRaluca Ana Maghinici
Raluca Ana Maghinici
Andreea-Loredana ComănescuAndreea-Loredana Comănescu
Andreea-Loredana Comănescu
AGAndrei Daniel Geman
Andrei Daniel Geman
Constantin ApetreiConstantin Apetrei
Constantin Apetrei
Nonsteroidal anti-inflammatory drugs such as phenylbutazone (PBZ) are among the most widely used medications globally due to their effectiveness in relieving pain and reducing inflammation. This study aims to detect PBZ with metallic particle-based electrochemical sensors using cyclic voltammetry (CV) in the presence of catechol as a redox probe. The approach focuses on evaluating the electrochemical behaviour of PBZ under different experimental conditions and optimizing the detection parameters to develop a simple, rapid, and cost-effective analytical method suitable for this pharmaceutical compound in lab practice. CV was performed using four types of screen-printed electrodes, each modified with different transitional metal particles, in potassium ferrocyanide/potassium ferricyanide, catechol, and catechol-PBZ solutions to study the electrochemical response and detection capability for PBZ. The best performance characteristics were obtained for the sensor modified with Ir particles that detect PBZ, with a linearity range of 0.01 to 1.00 μM and a detection limit of 1.53 nM. Additionally, Fourier-transform infrared spectroscopy (FT-IR) was used to characterize the PBZ in pharmaceuticals. The method using an iridium-modified sensor developed in this study allows the accurate detection of PBZ in pharmaceuticals with a relative error lower than 4%.